This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: **Fred Currell: Innovator in Radiation Treatment Simulation**
Introduction
Fred Currell is a prominent inventor based in Belfast, Great Britain. He has made significant contributions to the field of radiation treatment, where his innovative ideas have the potential to enhance patient care and treatment precision.
Latest Patents
Fred Currell holds a patent for a unique system and methods designed for accelerating the simulation of radiation treatment. This innovative method provides a comprehensive approach to estimating radiation dose and distribution for target volumes. The patent outlines a process that involves receiving a simulated dose array, generating an energy deposition coefficient function, and obtaining a raw fluence array. Further, it specifies the generation of an adjusted fluence array based on certain criteria, leading to the creation of an adjusted dose array tailored for the target volume.
Career Highlights
Throughout his career, Fred Currell has focused on developing solutions that address complex challenges in radiation therapy. His single patent signifies his dedication to advancing medical technology and improving treatment outcomes for patients requiring radiotherapy.
Collaborations
Fred has collaborated with various professionals in the field, including his coworker Marcus H. Mendenhall, to refine and advance his innovative methods. These collaborative efforts have been pivotal in driving the development of more effective radiation treatment strategies.
Conclusion
Fred Currell's work exemplifies the essence of innovation in the medical field. His patent serves as a testament to his ingenuity and commitment to improving radiation treatment processes, ultimately benefiting countless patients in need of this critical therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile